1. Home
  2. LYRA vs FGI Comparison

LYRA vs FGI Comparison

Compare LYRA & FGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LYRA
  • FGI
  • Stock Information
  • Founded
  • LYRA 2005
  • FGI 1987
  • Country
  • LYRA United States
  • FGI United States
  • Employees
  • LYRA N/A
  • FGI 420
  • Industry
  • LYRA Medical/Dental Instruments
  • FGI Industrial Specialties
  • Sector
  • LYRA Health Care
  • FGI Industrials
  • Exchange
  • LYRA Nasdaq
  • FGI Nasdaq
  • Market Cap
  • LYRA 6.1M
  • FGI 4.7M
  • IPO Year
  • LYRA 2020
  • FGI 2022
  • Fundamental
  • Price
  • LYRA $0.10
  • FGI $0.51
  • Analyst Decision
  • LYRA Hold
  • FGI
  • Analyst Count
  • LYRA 4
  • FGI 0
  • Target Price
  • LYRA $1.25
  • FGI N/A
  • AVG Volume (30 Days)
  • LYRA 1.7M
  • FGI 84.8K
  • Earning Date
  • LYRA 04-29-2025
  • FGI 05-07-2025
  • Dividend Yield
  • LYRA N/A
  • FGI N/A
  • EPS Growth
  • LYRA N/A
  • FGI N/A
  • EPS
  • LYRA N/A
  • FGI N/A
  • Revenue
  • LYRA $1,534,000.00
  • FGI $131,818,073.00
  • Revenue This Year
  • LYRA N/A
  • FGI $8.04
  • Revenue Next Year
  • LYRA $237.15
  • FGI $6.41
  • P/E Ratio
  • LYRA N/A
  • FGI N/A
  • Revenue Growth
  • LYRA N/A
  • FGI 12.43
  • 52 Week Low
  • LYRA $0.08
  • FGI $0.46
  • 52 Week High
  • LYRA $5.65
  • FGI $1.36
  • Technical
  • Relative Strength Index (RSI)
  • LYRA 38.11
  • FGI 34.67
  • Support Level
  • LYRA $0.08
  • FGI $0.48
  • Resistance Level
  • LYRA $0.10
  • FGI $0.64
  • Average True Range (ATR)
  • LYRA 0.02
  • FGI 0.08
  • MACD
  • LYRA 0.00
  • FGI 0.00
  • Stochastic Oscillator
  • LYRA 41.71
  • FGI 18.35

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

About FGI FGI Industries Ltd.

FGI Industries Ltd is a supplier of kitchen and bath products. The company is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. The company offers products that fall into four categories: Sanitaryware, Bath Furniture, Shower Systems and Other. The company generates the majority of its revenue from the sale of Sanitaryware products. Geographically, the company generates the majority of its revenue from the United States, followed by Canada and Europe.

Share on Social Networks: